-

Piper Sandler Companies Elects Stuart M. Essig to Board of Directors

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Stuart M. Essig, Ph.D. to its board of directors.

“Stuart will be a great asset to our board of directors. He brings deep experience and knowledge of the healthcare and medical technology industries, which remain important sectors for our investment banking business. In addition, his proven track record of leading a growing, publicly traded company will provide valuable perspective to the board,” said Chad Abraham, Piper Sandler chairman and chief executive officer.

Essig previously served as chief executive officer and director of Integra LifeSciences Corporation, a global medical technology company focused on innovative solutions for neurosurgery, tissue reconstruction, and advanced wound care, from 1997 to 2012. Following that, he has served as chairman from 2012 until today and executive chairman during 2024 and 2025. During Essig’s tenure, Integra LifeSciences grew revenues from approximately $15 million to more than $1.6 billion. Before joining Integra, Essig was a managing director in the healthcare group at Goldman Sachs where he had 10 years of experience, serving as a senior mergers and acquisitions advisor to a broad range of domestic and international medical technology, pharmaceutical and biotechnology clients.

In addition to serving as chairman of Integra, Essig currently serves on the board of directors at IDEXX Laboratories. From 1999 to 2017, he served on the board of directors at St. Jude Medical and has also sat on the boards of Zimmer Biomet, Owens & Minor and Orthofix. Essig earned a bachelor’s degree from the School of Public and International Affairs at Princeton University, and M.B.A. and Ph.D. degrees in financial economics from the University of Chicago, Graduate School of Business.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, a tied agent of AHP Capital Management GmbH, authorized and regulated by BaFin; in the Abu Dhabi Global Market through Piper Sandler MENA Ltd., authorized and regulated by the ADGM Financial Services Regulatory Authority; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

Follow Piper Sandler: LinkedIn | Facebook | X

©2026. Since 1895. Piper Sandler Companies. 350 North 5th Street, Minneapolis, Minnesota 55401

Contacts

Kate Clune
Chief Financial Officer
Tel: 212 466-7799
investorrelations@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Versions

Contacts

Kate Clune
Chief Financial Officer
Tel: 212 466-7799
investorrelations@psc.com

More News From Piper Sandler Companies

Piper Sandler Appoints Aamer Naseer to Head of Life Sciences Outsourcing and B2B Med Tech

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the appointment of Aamer Naseer to global head of life sciences outsourcing and B2B med tech. “Aamer has built deep relationships across the life sciences ecosystem and has a strong track record of advising private equity firms, public companies and founders/entrepreneurs. His leadership, sector expertise and commitment to our clients position us exceptionally well to continue e...

Piper Sandler Strengthens Healthcare Investment Banking Team with the Addition of Jason Arnold

MINNEAPOLIS & LONDON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Jason Arnold as a managing director in the healthcare investment banking group. Arnold will be initially based in London while serving clients globally. He will be advising life science tools and diagnostic companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “We’re delighted to welcome Jason to the healthcare i...
Back to Newsroom